Algernon Pharmaceuticals (AGNPF) Expected to Post Earnings on Friday

Algernon Pharmaceuticals (OTCMKTS:AGNPF) will likely be releasing its resultson Friday, July 24th. Analysts expect Algernon Pharmaceuticals to post earnings of ($4.9720) per share for the quarter.

Algernon Pharmaceuticals Stock Performance

OTCMKTS:AGNPF opened at $0.29 on Wednesday. Algernon Pharmaceuticals has a 1-year low of $0.23 and a 1-year high of $0.64. The business has a 50 day moving average of $0.31 and a 200 day moving average of $0.16.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.

The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).